Page 14 - Clinical Testing News Today

The LUCA device shows high accuracy in thyroid cancer screening Thyroid nodules are a common pathology having a prevalence of 19-76% when screened with ultrasound, with higher frequencies in women. Current medical methods used to assess the malignancy of a nodule consist in performing an ultrasound, followed by a Doppler ultrasound, and then a biopsy. However, unfortunately, these methods present both low specificity and low sensitivity. This insufficient effectiveness in accurately being able ...

/PRNewswire/ -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...

Share this article Share this article ResearchAndMarkets.coms offering. The Flow Cytometry Market is projected to grow at the rate of 8.7% CAGR by 2026. Flow cytometry is a biophysical, laser-based analytical technology that calculates and analyzes various physical features of cells or particles present in a fluid when passed through a laser beam. Flow cytometry has several benefits over conventional analytical techniques such as ELISA, including its capability to provide accurate results withi...

Phase 1 clinical study of unique vaccine to protect against COVID-19 begins A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command. Scientists developed a nanoparticle vaccine, based on a ferritin platform, which offers a flexible approach to targeting multiple variants of SARS-COV-2 and potentially other coronaviruses as well. The vaccine, called...

Twitter Facebook A year ago this week, Boston University made the unprecedented announcement that it was shutting down dorms and sending students home as the COVID-19 pandemic surged in Boston. As the one-year anniversary of that historic move approached, we invited members of the BU community to tell us their unsung heroes of the pandemic—a teacher, student, staff person, or alum who made a difference in their life, and the life of the University.  We heard from dozens of you, giving ...

COVID-19 vaccine candidate approved for human clinical testing A few days from now the first human will be vaccinated with a Danish vaccine candidate against COVID-19. It is developed by a team of researchers at the University of Copenhagen in collaboration with the companies AdaptVac, ExpreS2ion Biotechnologies and Bavarian Nordic. The vaccine candidate, ABNCoV2, has just been approved for human clinical testing. So far, the research data look promising. Our vaccine candidate is characterised ...

Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market - Strategy & Trends, Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country: Updated with Impact of COVID-19 - 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. The Clinical Laboratory has seen steady growth for the last 20 years, but this is changing with the effect of th...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost...

Share this article Share this article ResearchAndMarkets.coms offering. The global lateral flow assays market is projected to reach USD 10,230.3 million by 2025 from USD 8,205.3 million in 2020, at a CAGR of 4.5% during the forecast period. The growing prevalence of infectious diseases globally, increasing aging population, growing demand for point-of-care and home-based lateral flow assay devices, and increasing demand in food and environment safety and veterinary diagnostics industry are the...

Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., and Walgreens today announced that the FDA-authorized CRL Rapid Response COVID-19 Saliva Test is now available through Walgreens Find Care®, a digital health platform available on the Walgreens app and Walgreens.com. Sold under CRL's HealthConfirm® brand, the COVID-19 Saliva Test is non-invasive and highly accurate, offering consumers the convenience of self-collecting...